臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"莊伯恒 po heng chuang"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
中國醫藥大學	2014-10-05	Decline in quantitative serum HBsAg level during consolidation therapy following HBeAg loss in HBeAg-positive chronic hepatitis B patients treated with entecavir	蘇文邦(Wen-Pang Su);彭成元(Cheng-Yuan Peng)*;賴學洲(Hsueh-Chou Lai);林佳欣;莊伯恒(Po-Heng Chuang);陳昇弘(Sheng-Hung Chen)
中國醫藥大學	2014-09-07	Sorafenib Combined with Transarterial Chemoembolization or Radiation Therapy Versus Sorafenib Alone For Advanced Stage Hepatocellular Carcinoma –A Daily Practice Analysis	莊伯恒(Po-Heng Chuang);鄭隆賓(Long-Bin Jeng);賴學洲(Hsueh-Chou Lai);彭成元(Cheng-Yuan Peng);高榮達(Jung-Ta Kao);鄭庚申(Ken-Sheng Cheng)
中國醫藥大學	2014-03-09	Association between genotype and baseline HBsAg levels and the HBsAg levels at HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with entecavir	江承源(Cheng-Yuan Jiang);彭成元(Cheng-Yuan Peng)*;賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);林佳欣;莊伯恒(Po-Heng Chuang)
中國醫藥大學	2013-11-05	Predictive value of baseline and on-treatment quantitative serum HBsAg levels in therapeutic outcome to entecavir in patients with chronic hepatitis B.	彭成元(Cheng-Yuan Peng)*;賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);林佳欣;莊伯恒(Po-Heng Chuang);陳昇弘(Sheng-Hung Chen)
中國醫藥大學	2013-10-06	A Predictive Index using the Inosine Triphosphate Pyrophosphatase Gene Allele Status to Predict Ribavirin-induced Hemolytic Anemia in Genotype 1 Hepatitis C Virus-infected Asian Patients Receiving Pegylated Interferon and Ribavirin Combination Therapy	陳昇弘(Sheng-Hung Chen);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);莊伯恒(Po-Heng Chuang);高榮達(Jung-Ta Kao)
中國醫藥大學	2013-10-06	Predictive Value of Baseline and On-Treatment Quantitative Serum HBsAg Levels in Therapeutic Outcome to Entecavir in Patients with Chronic Hepatitis B	蔡宗佑;彭成元(Cheng-Yuan Peng)*;賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);林佳欣;莊伯恒(Po-Heng Chuang);蔡宗佑;彭成元(Cheng-Yuan Peng)
中國醫藥大學	2013-04-28	Predictive role of serum HBsAg level in genotype B or C HBeAg-negative chronic hepatitis B patients undergoing peginterferon therapy.	彭成元(Cheng-Yuan Peng)*;賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);林佳欣;莊伯恒(Po-Heng Chuang);高榮達(Jung-Ta Kao)
中國醫藥大學	2013-03-17	Evaluation of Decompensated Cirrhosis using Acoustic Radiation Force Impulse Elastography: comparisons with Child-Pugh and model for end-stage liver disease scores	陳昇弘(Sheng-Hung Chen);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);蔡松茂(Sung-Mao Tsai);陳昇弘(Sheng-Hung Chen)
中國醫藥大學	2013-03-17	Predictive role of quantitative serum HBsAg level in HBeAg-negative chronic hepatitis B patients undergoing peginterferon therapy	莊世杰(Shih-Chieh Chuang);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);莊伯恒(Po-Heng Chuang);高榮達(Jung-Ta Kao);莊世杰(Shih-Chieh Chuang);彭成元(Cheng-Yuan Peng)
中國醫藥大學	2012-10-07	Necroinflammatory effects on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in Asian patients with chronic hepatitis B	陳昇弘(Sheng-Hung Chen);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);蘇文邦(Wen-Pang Su);陳昇弘(Sheng-Hung Chen);李郁芬(Yu-Fen Li)
中國醫藥大學	2012-10-07	The clinical feature of intrahepatic cholangiocarcinoma	鄭庚申(Ken-Sheng Cheng);卓富讚(Fu-Tsan Chou);周仁偉(Jen-Wei Chou);余承儒(Cheng-Ju Yu);莊伯恒(Po-Heng Chuang);楊美都(Mei-Due Yang);鄭庚申(Ken-Sheng Cheng);鄭庚申(Ken-Sheng Cheng)
中國醫藥大學	2012-08	Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C	陳昇弘(Sheng-Hung Chen); 李郁芬(Yu-Fen Li); 賴學洲(Hsueh-Chou Lai); 高榮達(Jung-Ta Kao); 彭成元(Cheng-Yuan Peng)*; 莊伯恒(Po-Heng Chuang); 蘇文邦(Wen-Pang Su); 江宜平(I-Ping Chiang)
中國醫藥大學	2012-03-25	Complications of Radiofrequency Ablation Based Focal Therapies to Hepatic Tumors	莊伯恒(Po-Heng Chuang);彭成元(Cheng-Yuan Peng);鄭庚申(Ken-Sheng Cheng);賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);陳昇弘(Sheng-Hung Chen)
中國醫藥大學	2012-02-19	NONINVASIVE ASSESSMENT OF LIVER FIBROSIS VIA SPLEEN STIFFNESS MEASUREMENT USING ACOUSTIC RADIATION FORCE IMPULSE SONOELASTOGRAPHY IN PATIENTS WITH CHRONIC HEPATITIS B OR C	陳昇弘(Sheng-Hung Chen);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);蘇文邦(Wen-Pang Su);江宜平(I-Ping Chiang)
中國醫藥大學	2012-02-19	RFA immediately after PEI for treating HCC might increase the risk of delayed pyogenic liver abscess	莊伯恒(Po-Heng Chuang);彭成元(Cheng-Yuan Peng);賴學洲(Hsueh-Chou Lai);蘇文邦(Wen-Pang Su);馮俊龍(Chun-Lung Feng);陳昇弘(Sheng-Hung Chen);高榮達(Jung-Ta Kao)
中國醫藥大學	2011-06-29	一項臨床第四期、單組、開放性試驗，評估sorafenib(Nexavar蕾莎瓦R)使用於晚期肝細胞腫瘤(肝癌)患者	鄭隆賓(Long-Bin Jeng)*;楊宏仁(Horng-Ren Yang);楊美都(Mei-Due Yang);莊伯恒(Po-Heng Chuang);彭成元(Cheng-Yuan Peng);蘇文邦(Wen-Pang Su);賴學洲(Hsueh-Chou Lai);鄭庚申(Ken-Sheng Cheng);高榮達(Jung-Ta Kao);陳永芳(Yung-Fang Chen);陳德鴻(Te-Hong Chen
中國醫藥大學	2011-03	Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.	彭成元(Cheng-Yuan Peng)*; 陳志濱(Chih-Bin Chen); 賴學洲(Hsueh-Chou Lai); 蘇文邦(Wen-Pang Su); 莊伯恒(Po-Heng Chuang); 吳宏達(Hong-Dar Isaac Wu); 鄭隆賓(Long-Bin Jeng)
中國醫藥大學	2011-03	Primary small intestinal natural killer/t cell lymphoma mimicking tuberculous peritonitis: report of a case and review of the literature.	林晏年(Yen-Nien Lin); 周仁偉(Jen-Wei Chou)*; 莊伯恒(Po-Heng Chuang); 鄭庚申(Ken-Sheng Cheng); 彭成元(Cheng-Yuan Peng); 江宜平(I-Ping Chiang)
中國醫藥大學	2010-12-29	比較 LINIFANIB(ABT-869)與SPORAFENIB 對晚期肝細胞癌(HCC)病患的療效及耐受性之開放型，隨機，第三期試驗	鄭隆賓(Long-Bin Jeng)*;楊宏仁(Horng-Ren Yang);楊美都(Mei-Due Yang);莊伯恒(Po-Heng Chuang);彭成元(Cheng-Yuan Peng);蘇文邦(Wen-Pang Su);賴學洲(Hsueh-Chou Lai);鄭庚申(Ken-Sheng Cheng);高榮達(Jung-Ta Kao);陳永芳(Yung-Fang Chen)
中國醫藥大學	2010-08-31	一項隨機分配、雙盲、多中心的第三期臨床研究，對於患者有晚期肝細胞癌(HCC)但對SORAFENIB治療失敗或不耐受的受試者，施以BRIVANIB加上最佳支持行照顧(BSC)與安慰劑加上最佳支持性照護(BSC)之比較：BRISK PS	鄭隆賓(Long-Bin Jeng)*;楊美都(Mei-Due Yang);彭成元(Cheng-Yuan Peng);鄭庚申(Ken-Sheng Cheng);楊宏仁(Horng-Ren Yang);蘇文邦(Wen-Pang Su);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);賴學洲(Hsueh-Chou Lai);陳永芳(Yung-Fang Chen)
中國醫藥大學	2010-08-12	一項隨機分配、雙盲、多中心的第III期試驗，以BIVANIB相對於安慰劑作為經動脈化療栓塞術(TACE)之輔助療法，用於無法藉由手術切除肝細胞癌之病患：BRISK TA 試驗	鄭隆賓(Long-Bin Jeng)*;楊美都(Mei-Due Yang);彭成元(Cheng-Yuan Peng);鄭庚申(Ken-Sheng Cheng);楊宏仁(Horng-Ren Yang);蘇文邦(Wen-Pang Su);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);賴學洲(Hsueh-Chou Lai);陳永芳(Yung-Fang Chen)
中國醫藥大學	2010-06-30	一項隨機分配、雙盲、多中心的第三期臨床研究，對於患者晚期肝細胞癌之病患，以BRIVANIB或SORAFENIB作為第一線治療之比較(BRISK FL研究)』	鄭隆賓(Long-Bin Jeng)*;楊美都(Mei-Due Yang);彭成元(Cheng-Yuan Peng);鄭庚申(Ken-Sheng Cheng);楊宏仁(Horng-Ren Yang);蘇文邦(Wen-Pang Su);高榮達(Jung-Ta Kao);莊伯恒(Po-Heng Chuang);賴學洲(Hsueh-Chou Lai);陳永芳(Yung-Fang Chen)
中國醫藥大學	2009-09-27	Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan	賴學洲(Hsueh-Chou Lai); 澎成元(CY Peng); 蘇文邦(Wen-Pang Su); 莊伯恒(Po-Heng Chuang); 高榮達(Jung-Ta Kao); 周仁偉(Jen-Wei Chou); 賴學洲(Hsueh-Chou Lai)
中國醫藥大學	2009-07-11	(Case discussion) Successful RFA with PEI to one 3.7 cm HCC at S6 tip high risk location	莊伯恒(Po-Heng Chuang)*; 彭成元(Cheng-Yuan Peng); 高榮達(Jung-Ta Kao); 陳昇弘(Sheng-Hung Chen); 蔡金記(Chin-Chi Tsai); 鄭庚申(Ken-Sheng Cheng); 莊伯恒(Po-Heng Chuang)
中國醫藥大學	2009-07-11	(Case discussion) Successful RFA with PEI to one 3.7 cm HCC at S6 tip high risk location	莊伯恒(Po-Heng Chuang)*; 彭成元(Cheng-Yuan Peng); 高榮達(Jung-Ta Kao); 陳昇弘(Sheng-Hung Chen); 蔡金記(Chin-Chi Tsai); 鄭庚申(Ken-Sheng Cheng); 莊伯恒(Po-Heng Chuang)

Showing items 1-25 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52845608 ???header.onlineuser??? : 677 ???header.sponsordeclaration???